Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Paclitaxel
78%
P-Glycoprotein
55%
Antiinfective Agent
40%
Bioavailability
34%
Chronic Kidney Failure
31%
Pharmacokinetic Modeling
28%
Acute Coronary Syndrome
26%
Warfarin
26%
Cohort Study
26%
Pharmacokinetic Parameter
21%
Glycoprotein P Inhibitor
21%
Hepatotoxicity
20%
Gefitinib
20%
Risperidone
20%
Paliperidone
20%
Therapeutic Use
20%
Combination Therapy
20%
Bevacizumab
19%
Piperacillin Plus Tazobactam
18%
Retrospective Study
16%
Metastatic Breast Cancer
15%
Prospective Study
15%
Maintenance Dose
15%
Cefepime
15%
Pharmacovigilance
15%
Breast Cancer
14%
Mortality Rate
14%
Drug
13%
Pharmacology
13%
Antiplatelet
13%
Cefazolin
13%
Acetylsalicylic Acid
13%
Ferulic Acid
13%
Cytochrome P450 Inducer
13%
Linezolid
13%
Cytokine
13%
Coumarin Derivative
13%
Rivaroxaban
13%
Rifampicin
13%
Rat Model
13%
Piperazine Derivative
13%
Budesonide
13%
Chronic Graft Versus Host Disease
13%
Levodopa Methyl Ester
13%
Colistimethate
13%
Teicoplanin
13%
Repurposing
13%
Taxane
13%
Metastatic Colorectal Cancer
13%
Nursing and Health Professions
Antimicrobial Stewardship
34%
Communication Skill
30%
Meta Analysis
26%
Clinical Outcome
26%
Health Care Personnel
22%
Hospital Department
21%
Counseling
17%
Length of Stay
16%
Likert Scale
15%
Patient Counseling
15%
Outpatient
15%
Odds Ratio
15%
Mortality Rate
14%
Antiinfective Agent
14%
Medication Therapy Management
13%
International Normalized Ratio
13%
Heart Valve Replacement
13%
Pilot Study
13%
Health Literacy
13%
Anticoagulation
13%
Mechanical Heart Valve
13%
Local Therapy
13%
Budesonide
13%
Chronic Graft Versus Host Disease
13%
Pharmacy Student
13%
Thrombocytopenia
13%
Dexamethasone
13%
Warfarin
13%
Pain Intensity
13%
Analgesic Agent
13%
Practice Guideline
11%
University Hospital
11%
Chronic Kidney Failure
10%
Drug Use
10%
Confidence Interval
9%
Outpatient Department
8%
Dipeptidyl Carboxypeptidase Inhibitor
8%
Cohort Analysis
8%
Effect Size
8%
Treatment Outcome
7%
Elderly Patient
6%
Artificial Respiration
6%
Athletes
6%
Renin
6%
Angiotensin
6%
Cross-Sectional Study
6%
Gastrointestinal Agent
6%
Care Group
6%
Extended Spectrum Beta Lactamase
6%
Acute Coronary Syndrome
6%
Medicine and Dentistry
Antiinfective Agent
40%
Geriatric Assessment
26%
Retrospective Cohort Study
20%
Cancer Surgery
17%
Drug Use
16%
Anticoagulation
15%
Outpatient
15%
Polypharmacy
15%
Chronic Kidney Disease
15%
Prospective Study
15%
Awareness
14%
Myasthenia
13%
Chronic Hepatitis C
13%
Peginterferon
13%
Gynecological Oncology
13%
Surgical Mortality
13%
Mechanical Heart Valve
13%
Warfarin
13%
Valve Replacement
13%
Gefitinib
13%
Liver Toxicity
13%
Thromboprophylaxis
13%
Acetylsalicylic Acid
13%
Hip Arthroplasty
13%
Rivaroxaban
13%
Local Therapy
13%
Chronic Graft Versus Host Disease
13%
Dexamethasone
13%
Budesonide
13%
Meta-Analysis
13%
Health Care Cost
13%
Attributable Risk
13%
Mortality Rate
12%
Odds Ratio
11%
Antiviral Therapy
10%
Myasthenia gravis
10%
Interferon
8%
Thymus Cancer
8%
Cohort Analysis
6%
Liver Transplantation
6%
Venous Thromboembolism
6%
Long Term Survival
6%
Potential Barrier
6%
Network Meta-Analysis
6%
Renin-Angiotensin System Inhibitor
6%
Angiotensin Receptor Antagonist
6%
Antihypertensive Agent
6%
Kidney Function
6%
Glycon
6%
Renal Replacement Therapy
6%
